Business Analyst - Magellan, Customer to Cash jobs in United States
cer-icon
Apply on Employer Site
company-logo

Boston Scientific · 1 month ago

Business Analyst - Magellan, Customer to Cash

Boston Scientific is a leader in medical science committed to solving important health industry challenges. The Business Analyst role focuses on driving global transformation of Customer to Cash processes within their next-generation ERP system, supporting requirements gathering, process harmonization, and collaboration across various teams.

Health CareMedicalMedical Device
badNo H1Bnote

Responsibilities

Identify global functionality requirements for key CtC processes (including but not limited to Sales Order Management, Pricing and Rebate Processing, Billing Processing, and Accounts Receivable Management) within SAP S/4, with a focus on future state capabilities
Represent business users and stakeholders to define user requirements and translate them into user stories including the “Who, What, and Why” with clear acceptance criteria
Collaborate across project workstreams, capability owners, strategic integration vendors, Business Process Leads (BPLs), Subject Matter Experts (SMEs), Communities of Practice (CoPs), IT Solution Architects/COE, and other stakeholders to develop deep expertise in Customer to Cash process flows
Partner with the Change Enablement team and Site Leads/BPLs/SMEs to develop training plans and content for key functionality
Work collaboratively within a dynamic team that values constructive feedback, open dialogue, and professional growth
Support data migration efforts from SAP ECC to SAP S/4HANA through rigorous validation and stakeholder collaboration

Qualification

SAP S/4HANASAP SalesDistributionBusiness analysisCustomer to Cash processesERP systems knowledgeContinuous improvement mindsetCollaboration skillsCommunication skills

Required

Bachelor's degree in Business, Engineering, Science, or Supply Chain–related field
Minimum of 3 years' experience with SAP Sales and Distribution processes or SAP Master Data creation and maintenance
Strong working knowledge of SAP Master Data (Customer Master, Material Master, Sales Master Data) and related processes
Knowledge of end-to-end processes within the Customer to Cash space
Minimum of 2–4 years' experience in business analysis or similar roles supporting order-to-cash or customer-facing processes
Exposure to SAP S/4HANA or SAP ECC modules such as SD, MM, or FI-AR
Basic understanding of order processing, pricing, billing, returns, and financial flows
Experience documenting requirements and supporting testing activities
Working knowledge of ERP systems and related application ecosystems and interfaces
Demonstrated continuous improvement mindset, with experience in system upgrades, enhancements, or Lean business processes
Ability to establish, communicate, and engage teams in the vision and strategy of the Magellan Program
Strong collaboration and influencing skills across functions and levels

Preferred

Experience in the medical device or other regulated life sciences industries
Functional or operational experience with SAP Order to Cash in a medical device environment
Knowledge of life sciences processes and technology
Previous experience leading or supporting a major program introduction or upgrade, ideally within an IT/Systems or business representative role

Benefits

The value of core and optional employee benefits offered by Boston Scientific (BSC) – see www.bscbenefitsconnect.com
Compensation for non-exempt (hourly), non-sales roles may also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements)
Compensation for exempt, non-sales roles may also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements)

Company

Boston Scientific

company-logo
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.

Funding

Current Stage
Public Company
Total Funding
$10.02B
2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B

Leadership Team

leader-logo
Michael Mahoney
Chairman, President & CEO
linkedin
leader-logo
Daniel J. Brennan
Chief Financial Officer
linkedin
Company data provided by crunchbase